Engineered Matrix to Improve T Cell Immunotherapy

Researchers from Johns Hopkins University have developed an “artificial lymph node” to help multiply antigen-specific T cells to fight cancer. They used a hydrogel that contains immunostimulatory antigen-presenting nanoparticles to encourage T cells to proliferate, and have increased activity against specific antigens. Current T-cell based therapie (Read more...)

Full Story →